本页面由Tiger Trade Technology Pte. Ltd.提供服务

BioAge Labs Inc.

5.94
-0.4000-6.31%
成交量:48.22万
成交额:288.46万
市值:2.73亿
市盈率:-2.51
高:6.30
开:6.24
低:5.88
收:6.34
52周最高:25.96
52周最低:5.04
股本:4,589.69万
流通股本:3,757.56万
量比:0.38
换手率:1.28%
股息:- -
股息率:- -
每股收益(TTM):-2.3710
每股收益(LYR):-2.2432
净资产收益率:-28.21%
总资产收益率:-18.47%
市净率:0.73
市盈率(LYR):-2.65

数据加载中...

2026/10/02

重要事件披露

Form 8-K - Current report
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/05

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/05

重要事件披露

Form 8-K - Current report
2026/06/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/12

重要事件披露

Form 8-K - Current report
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/08

重要事件披露

Form 8-K - Current report
2026/05/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/04/28

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/24

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/03/24

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/24

重要事件披露

Form 8-K - Current report
2026/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/22

重要事件披露

Form 8-K - Current report
2026/01/20

重要事件披露

Form 8-K - Current report